KKR leads bidding race for minority stake in Malaysia's Avisena, sources say
KKR•Avisena's background and operations
Avisena began as a small medical facility in Shah Alam in 1996 and was rebranded in 2018, according to its website. It has since expanded and now includes Avisena Specialist Hospital, Avisena Specialist Hospital 2 and Avisena Renal Care.
It has five medical facilities, more than 75 resident specialists across 60 specialty areas and serves more than 250,000 local and international patients annually, its website showed.
Earlier shortlist included Bain Capital and KV Asia
Reuters reported on July 2 that global investment firms Bain Capital, KKR and Southeast Asia-focused private equity firm KV Asia Capital had been shortlisted to buy about 20% to 25% of Avisena in a deal that could be worth 300 million to 400 million ringgit.
KKR and Bain Capital declined to comment. Avisena Healthcare and KV Asia did not immediately respond to requests for comment.
KKR emerges as preferred bidder for Avisena minority stake
KKR & Co has emerged as the preferred bidder to buy a minority stake in Avisena Healthcare in a deal that could value the Malaysian healthcare firm at about 1.5 billion ringgit ($370 million), two people with direct knowledge of the matter said.
The parties could sign a deal as soon as early September, the people said, declining to be named as the matter is private.
